Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

TCRX TScan Therapeutics Inc

3,065

-0,02 (-0,65%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

TScan Therapeutics (NASDAQ:TCRX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more TScan Therapeutics Charts.

TScan Therapeutics (NASDAQ:TCRX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more TScan Therapeutics Charts.

News TScan Therapeutics Inc

Form 424B5 - Prospectus [Rule 424(b)(5)]
Donnerstag 26 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium
Donnerstag 26 Dezember 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 23 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank
Montag 23 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 10 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition
Montag 9 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years
Donnerstag 5 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Heme Development Strategy
Montag 2 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere TScan Therapeutics Inc News-Artikel

Health Care Select Sector

Deutsche Telekom (QX)

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen